Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease
NCT01599702
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Inflammatory Bowel Disease
Interventions
DRUG:
Iron Isomaltoside 1000
Sponsor
Pharmacosmos A/S